Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
MilliporeSigma and The Jenner Institute announced The Jenner Institute has laid the foundation for large-scale production of its Covid-19 vaccine candidate, ChAdOx1 nCoV-19.
read more
Wednesday, October 15, 2025
MilliporeSigma announced that the Life Science business of Merck KGaA, Darmstadt, Germany has signed a definitive agreement to acquire the chromatography business of JSR Life Sciences, a provider of contract development and manufacturing, preclinical...
read more
MilliporeSigma has announced an expansion of its Carlsbad, California facility to meet growing demand for viral and gene therapy products.
read more
Tuesday, February 18, 2020
MilliporeSigma has been selected by Swedish molecular diagnostics firm Elypta as the contract manufacturer for Elypta’s clinical diagnostic liquid biopsy kits.
read more
Wednesday, December 07, 2016
MilliporeSigma will provide its Provantage® End-to-End services to Acticor Biotech SAS for accelerated development and manufacturing of Acticor's antibody fragment used for the primary treatment of ischemic stroke.
read more
MilliporeSigma has formed a strategic alliance with Baylor College of Medicine for Vaccine Development to advance vaccine research and development for neglected and emerging infections.
read more
Thursday, August 02, 2018
MilliporeSigma and InnoCore Pharmaceuticals have entered into a global cooperation agreement to provide InnoCore’s proprietary SynBiosys biodegradable polymer platform.
read more
Wednesday, November 01, 2017
MilliporeSigma announced the signing of a MoU with Samsung BioLogics for a strategic alliance on biopharmaceutical manufacturing and biologics process development.
read more
MilliporeSigma and Schneider Electric announced the signing of a MoU that aims to automate biopharmaceutical processes for China’s biopharmaceutical industry.
read more
Wednesday, March 14, 2018
Minakem has initiated the extension of its manufacturing capacity at its Dunkirk site in France.
read more
Minaris, a CGT CDMO and multimodality biosafety testing provider and Chimeric Therapeutics, an Australian cell therapy company, announced a 100% batch manufacturing and release success rate in support of Chimeric Therapeutics' CDH17-targeted ...
read more
Thursday, August 03, 2023
Mind Medicine announced that it has entered into a license agreement with Catalent to access the company’s proprietary Zydis® orally disintegrating tablet (ODT) technology.
read more
Tuesday, January 25, 2022
Mindset Pharma Inc. has entered into a pharmaceutical manufacturing agreement with a leading contract development and manufacturing organization (CDMO), for the production of pharmaceutical grade batches of Mindset’s next-generation psilocybin drug ...
read more
Monday, February 26, 2018
Minerva Biotechnologies announced a European distribution agreement with CellSystems GmbH a European life science supplier, for AlphaSTEM Naïve Stem Cell Culture System.
read more
Tuesday, January 05, 2021
miRagen has gained exclusive rights to develop and commercialize therapeutic antibodies targeting IGF-1R incorporating Xtend Fc technology from Xencor.
read more